PTEN mutations are found in 10% of central nervous system and endometrial tumors, TSC1 mutations in 5%–6% of urinary tract and endometrial tumors, and TSC2 mutations in 4%–7% of gynecological, liver, and lung tumors. Here, PTEN is linked to endometrium neoplasm.